The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study.

Al Sulaiman, Khalid; Aljuhani, Ohoud; Alhammad, Abdullah M; Al Aamer, Kholoud; Alshehri, Sara; Alhuwahmel, Abdulmohsen; Kharbosh, Abdullah; Alshehri, Areej; Alshareef, Hanan; Al Sulaihim, Ibrahim; Alghamdi, Albandari; Al Harbi, Shmeylan; Vishwakarma, Ramesh; Alabdan, Numan; Alrajhi, Yousef; Al Katheri, Abdulmalik; Alenazi, Abeer A; Alalawi, Mai; Al Ghamdi, Ghassan

Al Sulaiman, Khalid; Aljuhani, Ohoud; Alhammad, Abdullah M; Al Aamer, Kholoud; Alshehri, Sara; Alhuwahmel, Abdulmohsen; Kharbosh, Abdullah; Alshehri, Areej; Alshareef, Hanan; Al Sulaihim, Ibrahim; Alghamdi, Albandari; Al Harbi, Shmeylan; Vishwakarma, Ramesh; Alabdan, Numan; Alrajhi, Yousef; Al Katheri, Abdulmalik; Alenazi, Abeer A; Alalawi, Mai; Al Ghamdi, Ghassan.

Afiliação

Al Sulaiman K; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Aljuhani O; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Alhammad AM; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Al Aamer K; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia.
Alshehri S; Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh, Saudi Arabia.
Alhuwahmel A; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Kharbosh A; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alshehri A; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Alshareef H; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Al Sulaihim I; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Alghamdi A; Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
Al Harbi S; Ferring Pharmaceuticals, Jeddah, Saudi Arabia.
Vishwakarma R; Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Alabdan N; Pharmaceutical Care Department, Presidency of State Security, Central Security Hospitals, Riyadh, Saudi Arabia.
Alrajhi Y; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia.
Al Katheri A; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Alenazi AA; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Alalawi M; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Al Ghamdi G; Statistics Department, European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.

Saudi Pharm J ; 30(12): 1748-1754, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36601502

Palavras-chave

AA, Ascorbic Acid; AKI, Acute Kidney Injury; Ascorbic Acid; CIN, Colistin-induced Nephrotoxicity; CKD, Chronic kidney disease; Colistin; Colistin-induced nephrotoxicity; HD, Hemodialysis; ICU, Intensive Care Unit; LOS, Length of Stay; MDR, Multiple drug resistance; Mortality; Nephrotoxicity; PS, Propensity Score; Vitamin C; XDR, Extensively drug-resistant

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google